InvestorsHub Logo
Followers 71
Posts 9382
Boards Moderated 0
Alias Born 07/17/2013

Re: CallMeCrazy post# 64178

Thursday, 07/31/2014 8:07:59 PM

Thursday, July 31, 2014 8:07:59 PM

Post# of 402582

CallMeCrazy Thursday, 07/31/14 07:58:51 AM
Re: Apparition post# 64173
Post # of 64210
Standard practice for Data Release In Clinical Trials:
I thought this might be helpful and would probably be a nice read for everyone on this board.

www.noodls.com/view/A66F1E690F52BB6C273A1CFFA22DDDA08B340D53?5162xxx1403360838



Thanks for the article Crazy. Maybe we should forward it to Menon.

“We will be presenting the most recent data available from the clinical trials of Kevetrin hosted at Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center,” said Dr. Krishna Menon, Chief Scientific Officer at Cellceutix. “We are acutely aware that the oncology community and shareholders have a strong interest".

As always, in my opinion only. Do your own due diligence!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News